A STUDY ON THE PREVALENCE AND ASSOCIATED FACTORS OF DYSLIPIDEMIA IN PATIENTS WITH KNEE OSTEOARTHRITIS AT CAN THO CITY GENERAL HOSPITAL

Quốc Tiến Nguyễn 1, Thế Vinh Nguyễn 1,
1 Võ Trường Toản University

Main Article Content

Abstract

Objectives: To investigate the prevalence and associated factors of dyslipidemia in patients with knee osteoarthritis. Materials and methods: A cross-sectional descriptive study was conducted on patients diagnosed with knee osteoarthritis according to the EULAR criteria, who were treated at Can Tho City General Hospital from January 2025 to September 2025. Results: A Total of 70 patients were enrolled, with a mean age: 58.86 ± 10.40 years. The proportion of severe knee osteoarthritis was 25.7%. The overall prevalence of dyslipidemia was 32.9%. By gender, dyslipidemia was observed in 33.3% of males and 32.7% of females. Patients with diabetes mellitus, severe osteoarthritis, obesity had a higher risk of dyslipidemia, with OR=2.85, OR=5.24, and OR=5.32, respectively. Conclusion: The proportion of dyslipidemia among patients with knee osteoarthritis was relatively high, accounting for approximately one-third of cases. Patients with diabetes, severe osteoarthritis and obesity were at a significantly higher risk of developing dyslipidemia compared to those without these risk factors.

Article Details

References

1. Wang H, et al. Metabolic syndrome increases the risk for knee osteoarthritis: a meta‐analysis. Evidence‐Based Complementary Alternative Medicine. 2016. 2016(1), p. 7242478.
2. Xiong J, et al. Dyslipidemia might be associated with an increased risk of osteoarthritis. BioMed research international. 2020. 2020(1), p. 3105248.
3. ZhangW, et al. EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis. Annals of the rheumatic diseases. 2010. 69(3), p. 483-489.
4. Ersan D. Comparison of 2019 and 2016 ESC/EAS Dyslipidemia Guidelines for Primary Prevention of Atherosclerotic Cardiovascular Disease. Kocaeli Medical Journal. 2023. 12(2),.
5. Baudart P, et al. Association between osteoarthritis and dyslipidaemia: a systematic literature review and meta-analysis. RMD open. 2017. 3(2), p. e000442.
6. Zhou M, et al. The cross-sectional and longitudinal effect of hyperlipidemia on knee osteoarthritis: Results from the Dongfeng-Tongji cohort. Scientific Reports. 2017. 7(1), p. 9739.
7. Chehade JM, Gladysz M. Dyslipidemia in type 2 diabetes: prevalence, pathophysiology, and management. Drugs. 2013. 73(4), p. 327-339.
8. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nature Reviews Endocrinology. 2009. 5(3), p. 150-159.